Lv32
210 积分 2026-04-17 加入
Initial results of a phase II study of nivolumab(N) and ipilimumab(I) in genitourinary malignancies with neuroendocrine differentiation
21天前
已关闭
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
洛铂对比顺铂同步放化疗治疗局部晚期鼻咽癌的疗效及安全性分析
1个月前
已完结
INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer—Toxicity Update on First 213 Patients
1个月前
已关闭
Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment
2个月前
已完结
皖公网安备34019202002308
